Sort   by:  
 Page size 
UnknownGarsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation.
Not available
S-EPMC12170901 | biostudies-literature
UnknownStroke genetics informs drug discovery and risk prediction across ancestries.
Not available
S-EPMC9524349 | biostudies-literature
UnknownElective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans.
Not available
S-EPMC7272903 | biostudies-literature
Sort   by:  
 Page size